Literature DB >> 10051088

The pharmacokinetics of morphine and lidocaine in critically ill patients.

H Berkenstadt1, E Segal, H Mayan, S Almog, M Rotenberg, A Perel, D Ezra.   

Abstract

OBJECTIVE: To evaluate the pharmacokinetic parameters of morphine and lidocaine after a single intravenous dose in critically ill patients.
DESIGN: Prospective, clinical study.
SETTING: General intensive care unit (ICU) in a university hospital. PATIENTS: Patients admitted to the ICU with severe systemic inflammatory response syndrome of various etiologies.
INTERVENTIONS: A single intravenous dose of morphine (0.025 mg/kg) and lidocaine (1.5 mg/kg) were given separately 12-36 h after admission, and arterial blood samples for serum drug levels were taken. MEASUREMENTS AND
RESULTS: Morphine pharmacokinetics were studied in 30 patients. The clearance (Cl) was found to be 5.7+/-2.3 ml/kg per min, volume of distribution of the central compartment (Vc) 0.16+/-0.12 l/kg and volume of distribution at steady state (Vss) 1.08+/-0.69 l/kg. These values are lower then those described previously for healthy volunteers (33.5+/-9 ml/kg per min, 1.01+/-0.31 l/kg, and 5.16+/-1.4 l/kg, respectively), and similar to those described in trauma and burned patients. Lidocaine pharmacokinetics were tested in 24 subjects. The Cl was 6.9+/-3.8 ml/kg per min, Vc 0.25+/-0.1 l/kg and Vss 0.78+/-0.26 l/kg. These values are not different from parameters published previously for healthy volunteers (10 ml/kg per min, 0.53 l/min and 1.32 l/min, respectively). No correlation was found between clinical variables and pharmacokinetic parameters of both drugs (ANOVA).
CONCLUSIONS: Both morphine and lidocaine have a reduced volume of distribution in critically ill patients. The normal lidocaine clearance indicates preserved hepatic blood flow and suggests that other mechanisms are involved in the reduced morphine clearance. These findings may have application for the treatment of ICU patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051088     DOI: 10.1007/s001340050796

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  5 in total

1.  Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates.

Authors:  Jeroen W B Peters; Brian J Anderson; Sinno H P Simons; Donald R A Uges; Dick Tibboel
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Dual modulation of the T-cell receptor-activated signal transduction pathway by morphine in human T lymphocytes.

Authors:  Toshiyuki Mizota; Hiroshi Tsujikawa; Takehiro Shoda; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2012-08-30       Impact factor: 2.078

3.  Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates.

Authors:  Jeroen W B Peters; Brian J Anderson; Sinno H P Simons; Donald R A Uges; Dick Tibboel
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

Review 4.  Recommendations for sepsis management in resource-limited settings.

Authors:  Martin W Dünser; Emir Festic; Arjen Dondorp; Niranjan Kissoon; Tsenddorj Ganbat; Arthur Kwizera; Rashan Haniffa; Tim Baker; Marcus J Schultz
Journal:  Intensive Care Med       Date:  2012-02-14       Impact factor: 17.440

Review 5.  Inter-individual variation in morphine clearance in children.

Authors:  Mohammed I Altamimi; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2015-04-08       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.